Renehavis

Renehavis

sodium hyaluronate

Manufacturer:

MDT International

Distributor:

The Glory Medicina
/
DKSH
Concise Prescribing Info
Contents
Per prefilled syringe Chamber 1: 2.2% low molecular wt Na hyaluronate (1 x 106 Da) 0.7 mL; Chamber 2: 1% high molecular wt Na hyaluronate (2 x 106 Da) 0.7 mL
Indications/Uses
Symptomatic relief of OA of the knee; relief of pain & stiffness of the knee joint in patients w/ degenerative changes to the synovial joint.
Dosage/Direction for Use
Intra-articular Inj into the affected synovial joint space once a wk up to 3 inj depending on the severity of the degenerative change to the knee joint.
Contraindications
Hypersensitivity.
Special Precautions
For single use only. Do not inj if there is evidence of skin disease or infection in the area of inj. Do not re-sterilised. Do not use for childn. Consider the immunological & potential risks that can be associated w/ the inj, as the Na hyaluronate is manufactured by fermentation of Strep equi & rigorously purified. Pregnancy & lactation.
Adverse Reactions
Transient pain & swelling. Transient increase in inflammation in the injected synovial joint in patients w/ inflammatory OA. Inflammatory reactions.
Drug Interactions
Avoid mixing or simultaneous administration w/ other intra-articular inj.
MIMS Class
Other Drugs Acting on Musculo-Skeletal System
ATC Classification
M09AX01 - hyaluronic acid ; Belongs to the class of other drugs for disorders of the musculo-skeletal system.
Presentation/Packing
Form
Renehavis inj
Packing/Price
1.4 mL x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in